ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2026
Exploring the Mechanism of Postpartum Cognitive Dysfunction in a Preeclampsia Rat Model via Multimodal Imaging.
Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Preeclampsia (PE) affects 3%-5% of pregnancies worldwide and is a leading cause of maternal/perinatal mortality, yet its etiology remains unknown. We established a PE rat model using L-NAME to investigate postpartum cognitive dysfunction and its mechanisms, evaluated brain microstructural changes with MRI, explored correlations between MRI parameters and cognitive impairment, and assessed pravastatin's therapeutic effects. Sixty-three pregnant rats were divided into normal pregnant (NP), PE, and pravastatin-treated (PRA) groups, with three postpartum subgroups (10 days, 1 month, 3 months; n = 7 each). Morris water maze, HE/Nissl staining, transmission electron microscopy, and multimodal MRI (DTI, IVIM, DCE-MRI) were performed. ROIs included anterior/posterior cortex and hippocampus. Pearson correlation was used to relate MRI parameters to escape latency. (1) L-NAME induced a PE-like phenotype, alleviated by pravastatin. (2) Cognitive impairment appeared at 10 days postpartum and worsened over time. (3) FA, D, and f values decreased while Ktrans increased in the PE group (p < 0.05), changes that progressed over time and were abrogated by pravastatin. (4) FA and D were negatively correlated with escape latency, whereas Ktrans showed a positive correlation. (5) Neuronal degeneration, astrocyte activation, and BBB disruption in the PE group were ameliorated by pravastatin. PE model rats developed progressive postpartum cognitive dysfunction, likely due to neuronal degeneration, glial activation, and increased BBB permeability. Pravastatin partially alleviated these pathological and cognitive changes. Multimodal MRI effectively detected alterations in brain microstructure, microvascular perfusion, and BBB, consistent with histopathological findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.